Title | Type | SJR | H index | Total Docs. (2009) | Total Docs. (3years) | Total Refs. (2009) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2009) | %Female (2009) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Drug Metabolism and Pharmacokinetics | journal | 0.981 Q1 | 75 | 72 | 185 | 2621 | 574 | 175 | 2.70 | 36.40 | 28.33 | |
52 | Pharmacotherapy | journal | 0.962 Q1 | 126 | 159 | 647 | 6164 | 2041 | 618 | 3.38 | 38.77 | 43.33 | |
53 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.954 Q1 | 52 | 27 | 72 | 2740 | 246 | 72 | 3.07 | 101.48 | 36.25 | |
54 | PPAR Research | journal | 0.952 Q1 | 59 | 39 | 169 | 2968 | 391 | 158 | 2.34 | 76.10 | 36.00 | |
55 | Current Treatment Options in Oncology | journal | 0.947 Q1 | 66 | 26 | 124 | 1640 | 301 | 123 | 2.36 | 63.08 | 23.81 | |
56 | Anti-Cancer Drugs | journal | 0.941 Q1 | 102 | 132 | 434 | 4194 | 1190 | 431 | 2.62 | 31.77 | 37.27 | |
57 | Cardiovascular Therapeutics | journal | 0.927 Q1 | 54 | 37 | 32 | 1698 | 93 | 28 | 2.91 | 45.89 | 21.85 | |
58 | Annals of Pharmacotherapy | journal | 0.910 Q1 | 122 | 288 | 1005 | 8088 | 2530 | 847 | 2.68 | 28.08 | 50.00 | |
59 | Psychopharmacology Bulletin | journal | 0.908 Q1 | 66 | 26 | 90 | 208 | 161 | 85 | 1.83 | 8.00 | 36.54 | |
60 | Pharmacopsychiatry | journal | 0.898 Q2 | 84 | 70 | 220 | 2806 | 449 | 180 | 2.11 | 40.09 | 28.03 | |
61 | Expert Review of Anticancer Therapy | journal | 0.895 Q2 | 85 | 166 | 539 | 11461 | 1262 | 492 | 2.40 | 69.04 | 26.58 | |
62 | HIV Clinical Trials | journal | 0.888 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
63 | Expert Opinion on Emerging Drugs | journal | 0.863 Q2 | 54 | 45 | 134 | 5224 | 386 | 134 | 3.00 | 116.09 | 26.23 | |
64 | Cardiology | journal | 0.858 Q2 | 72 | 141 | 375 | 3502 | 668 | 337 | 1.73 | 24.84 | 23.54 | |
65 | Therapeutic Drug Monitoring | journal | 0.858 Q2 | 102 | 99 | 384 | 3775 | 1060 | 360 | 2.73 | 38.13 | 36.67 | |
66 | Clinical Neuropharmacology | journal | 0.856 Q2 | 85 | 97 | 179 | 2350 | 507 | 165 | 2.80 | 24.23 | 33.43 | |
67 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.848 Q2 | 57 | 38 | 98 | 1324 | 219 | 94 | 2.27 | 34.84 | 32.14 | |
68 | European Journal of Clinical Pharmacology | journal | 0.845 Q2 | 123 | 171 | 508 | 5278 | 1428 | 452 | 2.80 | 30.87 | 38.76 | |
69 | Pulmonary Pharmacology and Therapeutics | journal | 0.842 Q2 | 81 | 91 | 283 | 4650 | 760 | 271 | 2.60 | 51.10 | 26.90 | |
70 | Journal of Aerosol Medicine and Pulmonary Drug Delivery | journal | 0.841 Q2 | 81 | 30 | 156 | 884 | 307 | 136 | 1.56 | 29.47 | 24.76 | |
71 | CNS Neuroscience and Therapeutics | journal | 0.839 Q2 | 91 | 35 | 31 | 2080 | 84 | 30 | 2.71 | 59.43 | 40.48 | |
72 | Breast Cancer | journal | 0.831 Q2 | 66 | 56 | 186 | 1337 | 410 | 183 | 2.32 | 23.88 | 22.39 | |
73 | American Journal of Cardiovascular Drugs | journal | 0.796 Q2 | 60 | 43 | 134 | 2160 | 338 | 128 | 2.63 | 50.23 | 24.24 | |
74 | Current Clinical Pharmacology | journal | 0.796 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
75 | Expert Opinion on Drug Safety | journal | 0.779 Q2 | 90 | 68 | 240 | 5545 | 673 | 192 | 2.84 | 81.54 | 27.71 | |
76 | Expert Review of Neurotherapeutics | journal | 0.775 Q2 | 98 | 147 | 519 | 13586 | 1289 | 466 | 2.49 | 92.42 | 30.00 | |
77 | Human Psychopharmacology | journal | 0.758 Q2 | 86 | 75 | 212 | 3679 | 540 | 204 | 2.56 | 49.05 | 32.92 | |
78 | Drugs and Aging | journal | 0.749 Q2 | 109 | 90 | 248 | 5633 | 659 | 236 | 3.01 | 62.59 | 39.12 | |
79 | Recent Patents on CNS Drug Discovery | journal | 0.743 Q2 | 36 | 19 | 70 | 2426 | 195 | 70 | 2.89 | 127.68 | 40.68 | |
80 | Journal of Ocular Pharmacology and Therapeutics | journal | 0.741 Q2 | 72 | 86 | 218 | 2478 | 407 | 213 | 1.84 | 28.81 | 30.81 | |
81 | Fundamental and Clinical Pharmacology | journal | 0.707 Q2 | 85 | 90 | 228 | 3924 | 546 | 222 | 2.37 | 43.60 | 35.31 | |
82 | Paediatric Drugs | journal | 0.700 Q2 | 70 | 52 | 137 | 2363 | 324 | 108 | 2.42 | 45.44 | 34.41 | |
83 | Chemotherapy | journal | 0.681 Q2 | 61 | 59 | 207 | 1858 | 392 | 202 | 2.08 | 31.49 | 37.20 | |
84 | Journal of Biopharmaceutical Statistics | journal | 0.642 Q2 | 56 | 80 | 233 | 1455 | 241 | 208 | 1.04 | 18.19 | 25.43 | |
85 | Acta Pharmacologica Sinica | journal | 0.624 Q2 | 117 | 199 | 659 | 8200 | 1233 | 657 | 1.81 | 41.21 | 41.71 | |
86 | Journal of Clinical Pharmacy and Therapeutics | journal | 0.622 Q2 | 81 | 90 | 264 | 2551 | 578 | 242 | 2.03 | 28.34 | 34.66 | |
87 | BMC Pharmacology | journal | 0.620 Q2 | 48 | 19 | 53 | 530 | 96 | 53 | 1.41 | 27.89 | 27.03 | |
88 | Vascular Health and Risk Management | journal | 0.616 Q2 | 82 | 110 | 330 | 6458 | 704 | 325 | 2.07 | 58.71 | 22.70 | |
89 | Expert Opinion on Pharmacotherapy | journal | 0.613 Q2 | 93 | 271 | 794 | 20462 | 1915 | 773 | 2.52 | 75.51 | 31.12 | |
90 | Reading Teacher | journal | 0.610 Q2 | 60 | 80 | 243 | 1594 | 183 | 241 | 0.63 | 19.93 | 83.97 | |
91 | BMC Clinical Pharmacology | journal | 0.599 Q2 | 43 | 19 | 34 | 679 | 84 | 34 | 2.46 | 35.74 | 39.22 | |
92 | Drug Information Journal | journal | 0.589 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
93 | Recent Patents on Cardiovascular Drug Discovery | journal | 0.589 Q2 | 30 | 28 | 78 | 2051 | 175 | 78 | 2.29 | 73.25 | 22.83 | |
94 | American Journal of Therapeutics | journal | 0.579 Q2 | 69 | 104 | 294 | 3290 | 517 | 270 | 1.71 | 31.63 | 28.09 | |
95 | Drugs of Today | journal | 0.569 Q2 | 57 | 102 | 266 | 6046 | 529 | 261 | 1.99 | 59.27 | 34.13 | |
96 | International Journal of Clinical Pharmacy | journal | 0.554 Q2 | 71 | 74 | 240 | 1717 | 332 | 226 | 1.26 | 23.20 | 48.71 | |
97 | International Journal of STD and AIDS | journal | 0.542 Q2 | 78 | 247 | 751 | 4520 | 882 | 651 | 1.12 | 18.30 | 42.54 | |
98 | International Journal of Clinical Pharmacology and Therapeutics | journal | 0.533 Q2 | 73 | 131 | 268 | 2903 | 434 | 245 | 1.62 | 22.16 | 29.50 | |
99 | Journal of Addiction Medicine | journal | 0.528 Q2 | 58 | 30 | 69 | 1530 | 60 | 61 | 0.87 | 51.00 | 37.59 | |
100 | Advances in Antiviral Drug Design | book series | 0.523 Q2 | 12 | 0 | 7 | 0 | 14 | 6 | 2.00 | 0.00 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®